Abstract
Background Polycystic ovary syndrome (PCOS) has been one of the important public health problems in Sudan, which leads to medical consequences and ends up in sterility.
Methods This study includes 40 PCOS women with age ranged between 16 and 40 years were selected based on Rotterdam criteria 2003 and 40 ovulatory normal non-PCOs, healthy and age-matched women as control. The lipid profiles (total cholesterol, LDL-C, HDL-C and triglyceride [TG]) were measured by an enzymatic colorimetric method using biosystem reagents. The data management and analysis were done with SPSS version 22.
Results There was no significant difference between the two groups in terms of age and body mass index except TG in PCOS ladies with BMI more than 25 was significantly higher in comparison with non-PCOs.
Conclusion This study does not guide the belief that PCOS affects serum lipid ranges, besides in the term of TG in PCOS girls with BMI >25. It is far advised to do this study in ladies with PCOS sufferers from insulin resistance.
Keywords
References
Iuhas C, Costin N, Mihu D. Lipid parameters in patients with polycystic ovary syndrome. Appl Med Informatics. 2012;31(4):27–32.
Allahbadia GN, Merchant R. Polycystic ovary syndrome and impact on health. Middle East Fertil Soc J. 2011;16(1):19–37.
Gambineri A, Pelusi C, Vicennati V, Pagotto U, Pasquali R. Obesity and the polycystic ovary syndrome. Int J Obes Relat Metab Disord. 2002;26(7):883–96.
Swetha N, Vyshnavi R, Modagan P, Rajagopalan B. A correlative study of biochemical parameters in polycystic ovarian syndrome. Int J Biol Med Res. 2013;4:3148–54.
Iuhas CI, Costin N, Mihu D. Lipid parameters in patients with polycystic ovary syndrome. Appl Med Inform Origin Res.2012;31:27–32.
Rizzo M, Berneis K, Carmina E, Rini GB. How should we manage atherogenic dyslipidemia in women with polycystic ovary syndrome? Am J Obstet Gynecol. 2008;198:28–5.
Valkenburg O, Steegers-Theunissen RP, Smedts HP, Dallinga- Thie GM, Fauser BC, Westerveld EH, et al. A more atherogenic serum lipoprotein profile is present in women with polycystic ovary syndrome: a case–control study. J Clin Endocrinol Metab. 2008;93:470–6.
Amini L, Sadeghi MR, Oskuie F, Kamali K, Maleki H. Lipid profile in women with polycystic ovary syndrome. Crescent J Med Biol Sci. 2014;1(4):147–50.
Bickerton AS, Clark N, Meeking D, Shaw KM, Crook M, Lumb P, et al. Cardiovascular risk in women with polycystic ovarian syndrome (PCOS). J Clin Pathol. 2005;58:151–4.
Swetha N, Vyshnavi R, Modagan P, Rajagopalan B. A correlative study of biochemical parameters in olycystic ovarian syndrome. Int J Biol Med Res. 2013;4:3148–54.
Latha M, Bhaskar MV, Sharma SSB, Sumapreethi A. Evaluation of dyslipidemia and oxidative stress in patients with polycystic ovarian syndrome. J Evol Med Dent Sci. 2012;1(5):769–775.
Shoaib O, Mustafa S, Nourein I. Serum lipid profile of polycystic ovary syndrome in Sudanese women. Int J Med Sci Public Heal [Internet]. 2015;4(11):1.
Silfen ME, Denburg MR, Manibo AM, Lobo RA, Jaffe R, Ferin M, et al. Early endocrine, metabolic, and sonographic characteristics of polycystic ovary syndrome (PCOS): comparison between nonobese and obese adolescents. J Clin Endocrinol Metab. 2003;88:4682–8.
Savic S, Zarkovic M, Ciric M, Beleslin B, Drezgic M, Trbojevic B. Lipid profile in normal weight and obese women with polycystic ovary syndrome. Endocr Abstracts. 2006;11:341.
Bachceci M, Aydemir M, Tuzcu A. Effects of oral fat and glucose tolerance test on serum lipid profile, apolipoprotein and CRP concentration, and insulin resistance in patients with polycystic ovary syndrome. Fertil Steril. 2007;87:1363–8.
Refbacks
- There are currently no refbacks.
Copyright (c) 2016 Journal of Pharmaceutical and Biomedical Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.